A detailed history of Virtus Investment Advisers, Inc. transactions in Gh Research PLC stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 7,329 shares of GHRS stock, worth $102,606. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,329
Holding current value
$102,606
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$8.66 - $13.79 $63,469 - $101,066
7,329 New
7,329 $89,000

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $728M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.